Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Logue

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 14, 2001
Patterns of relapse following radiotherapy for stage I seminoma of the testis: implications for follow-upJ E Livsey, B Taylor, N Mobarek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 30, 1999
Animation and radiobiological analysis of 3D motion in conformal radiotherapyR I MacKay, P A Graham, C J Moore, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Primary malignant lymphoma of the thyroid: a clinicopathological analysisJ P Logue, R J Hale, A L Stewart, et al.
Radiology|October 23, 2004
Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experienceDavid L Buckley, Caleb Roberts, Geoff J M Parker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 3, 2008
Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancerDarren M Mitchell, Ric Swindell, Tony Elliott, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 7, 2004
Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracyAnn M Henry, Cathy Wilkinson, James P Wylie, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 18, 2006
External-beam radiotherapy in T1-2 N0 penile carcinomaM Azrif, J P Logue, R Swindell, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity?Jacqueline E Livsey, James P Wylie, Ric Swindell, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 6, 2005
Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomyL W Lee, C A McBain, R Swindell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2009
Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicityJoanna H Coote, James P Wylie, Richard A Cowan, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 14, 2001
Patterns of relapse following radiotherapy for stage I seminoma of the testis: implications for follow-upJ E Livsey, B Taylor, N Mobarek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 30, 1999
Animation and radiobiological analysis of 3D motion in conformal radiotherapyR I MacKay, P A Graham, C J Moore, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Primary malignant lymphoma of the thyroid: a clinicopathological analysisJ P Logue, R J Hale, A L Stewart, et al.
Radiology|October 23, 2004
Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experienceDavid L Buckley, Caleb Roberts, Geoff J M Parker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 3, 2008
Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancerDarren M Mitchell, Ric Swindell, Tony Elliott, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 7, 2004
Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracyAnn M Henry, Cathy Wilkinson, James P Wylie, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 18, 2006
External-beam radiotherapy in T1-2 N0 penile carcinomaM Azrif, J P Logue, R Swindell, et al.
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity?Jacqueline E Livsey, James P Wylie, Ric Swindell, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 6, 2005
Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomyL W Lee, C A McBain, R Swindell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2009
Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: analysis of toxicityJoanna H Coote, James P Wylie, Richard A Cowan, et al.
Pageof 8